Caption Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $182K | Sell |
8,455
-56,769
| -87% | -$1.22M | ﹤0.01% | 426 |
|
|
2025
Q1 | $1.08M | Buy |
+65,224
| New | +$1.08M | 0.01% | 195 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 510 |
|
|
2024
Q3 | – | Sell |
-7,800
| Closed | -$127K | – | 430 |
|
|
2024
Q2 | $127K | Sell |
7,800
-58,800
| -88% | -$956K | ﹤0.01% | 306 |
|
|
2024
Q1 | $1.23M | Buy |
+66,600
| New | +$1.23M | 0.02% | 142 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 442 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 411 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 347 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 417 |
|
|
2022
Q3 | – | Sell |
-1,766
| Closed | -$25K | – | 507 |
|
|
2022
Q2 | $25K | Sell |
1,766
-17,034
| -91% | -$241K | ﹤0.01% | 447 |
|
|
2022
Q1 | $455K | Buy |
+18,800
| New | +$455K | 0.01% | 332 |
|
|
2021
Q4 | – | Sell |
-21,500
| Closed | -$357K | – | 544 |
|
|
2021
Q3 | $357K | Sell |
21,500
-35,500
| -62% | -$589K | ﹤0.01% | 374 |
|
|
2021
Q2 | $1.39M | Sell |
57,000
-54,700
| -49% | -$1.33M | 0.02% | 150 |
|
|
2021
Q1 | $2.88M | Buy |
111,700
+51,100
| +84% | +$1.32M | 0.06% | 72 |
|
|
2020
Q4 | $3.24M | Buy |
60,600
+25,600
| +73% | +$1.37M | 0.07% | 50 |
|
|
2020
Q3 | $1.44M | Sell |
35,000
-15,457
| -31% | -$638K | 0.03% | 91 |
|
|
2020
Q2 | $2.45M | Buy |
+50,457
| New | +$2.45M | 0.08% | 57 |
|
|
2020
Q1 | – | Sell |
-20,700
| Closed | -$885K | – | 308 |
|
|
2019
Q4 | $885K | Sell |
20,700
-4,300
| -17% | -$184K | 0.03% | 120 |
|
|
2019
Q3 | $899K | Buy |
+25,000
| New | +$899K | 0.05% | 96 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 235 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 191 |
|
|
2018
Q3 | – | Sell |
-36,000
| Closed | -$549K | – | 199 |
|
|
2018
Q2 | $549K | Buy |
+36,000
| New | +$549K | 0.04% | 109 |
|